Evidence map›Paper›PMID 28523431›Full record

ArticleThe Psychiatric quarterly2018

The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool.

Leo Bastiaens, James Galus

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in The Psychiatric quarterly, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07192601 (Developing an E-Cigarette Cessation Intervention for Hispanic/Latina), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07192601 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida

TypeinterventionalSponsorFlorida International UniversityRan2024 to 2028Enrolled120ConditionsVaping Teens, Vaping Behaviors, Vaping Cessation, Tobacco Use DisorderArmsE-cigarette Cessation Manual
3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Examining the factor structure of the DSM-5 Level 1 cross-cutting symptom measure.International journal of methods in psychiatric research · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leo BastiaensRenewal Treatment, Inc., 700 Fifth Ave, Pittsburgh, PA, 15219, USA. lbastiaens@Renewalinc.com.ORCID 0000-0003-1975-2846
James GalusRenewal Treatment, Inc., 700 Fifth Ave, Pittsburgh, PA, 15219, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure was developed to aid clinicians with a dimensional assessment of psychopathology; however, this measure resembles a screening tool for several symptomatic domains. The objective of the current study was to examine the basic parameters of sensitivity, specificity, positive and negative predictive power of the measure as a screening tool. One hundred and fifty patients in a correctional community center filled out the measure prior to a psychiatric evaluation, including the Mini International Neuropsychiatric Interview screen. The above parameters were calculated for the domains of depression, mania, anxiety, and psychosis. The results showed that the sensitivity and positive predictive power of the studied domains was poor because of a high rate of false positive answers on the measure. However, when the lowest threshold on the Cross-Cutting Symptom Measure was used, the sensitivity of the anxiety and psychosis domains and the negative predictive values for mania, anxiety and psychosis were good. In conclusion, while it is foreseeable that some clinicians may use the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a screening tool, it should not be relied on to identify positive findings. It functioned well in the negative prediction of mania, anxiety and psychosis symptoms.

Indexed as

Diagnostic and Statistical Manual of Mental DisordersAdultAnxietyAnxiety DisordersBipolar DisorderDepressionDepressive DisorderFemaleHumansMaleMiddle AgedPsychiatric Status Rating ScalesPsychotic DisordersSensitivity and SpecificityDSM-5 self-rated level 1 cross-cutting symptom measureScreen

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.